BackIntensity Therapeutics Overview
Intensity Therapeutics Inc

Intensity Therapeutics Discounted Cash Flow

DCF fair value estimate for Intensity Therapeutics: $0.87.

Get informed when a big investor buys or sells

+ Follow

Fair Value

$0.87

Current Fair Value

$0.87
↓ 78.8% Downside

Overvalued by 78.8% based on the discounted cash flow analysis.

Average Upside/Downside (Comparison Companies)

Loading

Fair Value vs. Stock Price History

Loading

Upside/Downside History

Loading

Upside/Downside Comparison

Loading

Intensity Therapeutics (INTS) FAQ

Intensity Therapeutics posts a DCF fair value of $0.87. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

Markets price INTS on many factors — sentiment, liquidity, and near-term news — while DCF focuses on long-run cash flows. The current fair-value estimate of $0.87 sits 78.8% below the live price. Large gaps can highlight opportunity or model risk; the charts on this page help you see how the estimate has moved over time.

Context for INTS's DCF fair value usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Intensity Therapeutics's other metric pages and overview cover the third.